Skip to main content
Premium Trial:

Request an Annual Quote

Zygem Extraction Technology to be Used with Rubicon Kits

NEW YORK (GenomeWeb News) – Zygem and Rubicon Genomics have struck an agreement that will incorporate Zygem's enzymatic nucleic acid extraction technology with Rubicon's pre-analytical platform in an offering aimed at DNA and RNA analysis, Zygem said today.

The integration initially will focus on diagnostic single-cell whole genome amplification kits, but it could expand to include other research and diagnostic products, Zygem said.

The Zygem technology uses a thermophilic enzyme to extract DNA from samples using a closed-tube system, which the company said reduces the time and cost of the extraction process.

Rubicon plans to launch its PicoPlex kits, which integrate the Zygem system into a novel method to amplify single genomes, and is aimed at the genetic diagnostics and cancer diagnostics markets. The product will enable reference labs to begin qPCR, microarray, or sequencing analysis less than three hours after collecting patient cells.

Zygem also noted that the US Patent Office has issued an allowance for an application covering thermophilic enzymes that are used in its nucleic acid extraction technology, and that it expects the patent to be issued later this year.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.